Header Logo

Lauren Dockery

Concepts (68)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local
4
2025
330
1.410
 Why?
Ovarian Neoplasms
6
2025
589
1.280
 Why?
Uterine Cervical Neoplasms
2
2022
297
1.070
 Why?
Endometrial Neoplasms
2
2025
189
0.860
 Why?
Vulvar Neoplasms
1
2021
25
0.690
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2020
37
0.690
 Why?
Carcinoma in Situ
1
2021
46
0.680
 Why?
Disease Management
1
2021
88
0.650
 Why?
Platinum Compounds
1
2019
14
0.630
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2022
407
0.580
 Why?
United States Indian Health Service
1
2018
14
0.570
 Why?
Patient Navigation
1
2018
7
0.570
 Why?
Phthalazines
1
2017
22
0.540
 Why?
Piperazines
1
2017
47
0.530
 Why?
Neoplasms, Glandular and Epithelial
1
2017
72
0.520
 Why?
Antineoplastic Agents
1
2019
678
0.420
 Why?
Indians, North American
1
2018
521
0.420
 Why?
Female
10
2025
15157
0.330
 Why?
Bevacizumab
2
2022
103
0.330
 Why?
Molecular Targeted Therapy
2
2020
135
0.300
 Why?
Aged
5
2025
5399
0.280
 Why?
Retrospective Studies
4
2024
2543
0.250
 Why?
Aged, 80 and over
3
2025
2020
0.250
 Why?
Humans
10
2025
28101
0.240
 Why?
CD47 Antigen
1
2025
4
0.230
 Why?
CD40 Antigens
1
2025
14
0.230
 Why?
Machine Learning
1
2025
84
0.220
 Why?
Neoadjuvant Therapy
1
2024
73
0.210
 Why?
Prealbumin
1
2022
4
0.200
 Why?
Endometrium
1
2022
39
0.190
 Why?
Middle Aged
4
2025
7137
0.190
 Why?
Cervix Uteri
1
2022
65
0.180
 Why?
Indoles
1
2022
99
0.180
 Why?
Vulvar Lichen Sclerosus
1
2021
1
0.170
 Why?
Vulva
1
2021
5
0.170
 Why?
Papillomaviridae
1
2021
87
0.170
 Why?
Indazoles
1
2020
18
0.170
 Why?
Fallopian Tube Neoplasms
1
2020
52
0.160
 Why?
Piperidines
1
2020
48
0.160
 Why?
Peritoneal Neoplasms
1
2020
79
0.160
 Why?
Adult
3
2025
7739
0.150
 Why?
Papillomavirus Infections
1
2021
143
0.150
 Why?
Disease-Free Survival
1
2019
236
0.150
 Why?
Clinical Trials, Phase II as Topic
1
2017
25
0.140
 Why?
Patient Compliance
1
2018
75
0.140
 Why?
Clinical Trials, Phase I as Topic
1
2017
27
0.140
 Why?
Disease Progression
1
2019
473
0.140
 Why?
Treatment Outcome
2
2020
2378
0.130
 Why?
Randomized Controlled Trials as Topic
1
2017
385
0.120
 Why?
Risk Factors
1
2021
2081
0.120
 Why?
Age Factors
1
2017
734
0.120
 Why?
Prospective Studies
1
2017
1248
0.110
 Why?
United States
1
2018
2145
0.090
 Why?
Young Adult
1
2018
2733
0.080
 Why?
Adolescent
1
2018
3123
0.080
 Why?
Immunoglobulin Fc Fragments
1
2025
4
0.060
 Why?
Recombinant Fusion Proteins
1
2025
233
0.050
 Why?
Drug Resistance, Neoplasm
1
2025
167
0.050
 Why?
Interleukin-8
1
2022
44
0.050
 Why?
Cytoreduction Surgical Procedures
1
2022
33
0.050
 Why?
Vitamin D
1
2022
50
0.050
 Why?
Predictive Value of Tests
1
2024
474
0.050
 Why?
Chemotherapy, Adjuvant
1
2022
113
0.050
 Why?
Interleukin-6
1
2022
194
0.040
 Why?
Pilot Projects
1
2022
433
0.040
 Why?
Biomarkers
1
2022
766
0.040
 Why?
Postoperative Complications
1
2022
611
0.040
 Why?
Prognosis
1
2020
802
0.040
 Why?
Dockery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Co-Authors (18)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_